🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

11 results for “Denosumab” Clear

  1. denosumab

    CORORA Amgen

    SUBCUTANEOUS approved

    M05BX04

  2. denosumab-adet

    PONLIMSI Teva Pharma GmbH

    SUBCUTANEOUS approved

  3. denosumab-bbdz

    JUBBONTI

    SUBCUTANEOUS approved

  4. denosumab-bmwo

    OSENVELT

    INJECTION approved

  5. denosumab-bnht

    CONEXXENCE

    approved

  6. denosumab-desu

    OSVYRTI

    SUBCUTANEOUS approved

  7. denosumab-dssb

    DENOSUMAB-DSSB

    SUBCUTANEOUS approved

  8. denosumab-kyqq

    AUKELSO

    INJECTION approved

  9. denosumab-mobz

    BONCRESA Amneal Pharma Europe Ltd

    SUBCUTANEOUS approved

  10. denosumab-nxxp

    BILPREVDA

    INJECTION approved

  11. denosumab-qbde

    ENOBY

    INJECTION approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources